- জেনেরিক নাম
- Ferric Carboxymaltose
- শক্তি
- 500 mg/10 ml
- ডোজ ফর্ম
- Injection
- প্রস্তুতকারক
- The ACME Laboratories Ltd.
Hemorise 500 IV Injection
Hemorise 500 IV 500 mg/10 ml Injection সম্পর্কে
Hemorise 500 IV 500 mg/10 ml Injection একটি ইনজেকশন ঔষধ, যার জেনেরিক নাম Ferric Carboxymaltose এবং শক্তি ৫০০ mg/১০ ml। Hemorise 500 IV প্রস্তুত করেছে The ACME Laboratories Ltd। Ferric Carboxymaltose-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Ferric Carboxymaltose-এর ১৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Ferium Injection 500 mg/10 ml-এর, প্রতি ইউনিট ৳ ৭০০।
Hemorise 500 IV 500 mg/10 ml Injection কী?
Hemorise 500 IV 500 mg/10 ml injection is a medicine made by The ACME Laboratories Ltd. When body iron stores fall, anaemia can develop. It is given by a healthcare professional, not by the patient at home. The dose and course are decided by the doctor.
Hemorise 500 IV-এর ব্যবহার
It is intended for people who do not tolerate iron taken by mouth or who have not had a satisfactory response to oral iron. Hemorise 500 IV is used to treat iron deficiency anemia in adults who have intolerance to oral iron or an unsatisfactory response to oral iron, and in adults with non-dialysis dependent chronic kidney disease. It helps replace iron stores in the body. Ask your doctor whether it is right for your condition.
Hemorise 500 IV কীভাবে ব্যবহার করবেন
You should not self-administer it. Do not inject it yourself unless a doctor has shown you how. Hemorise 500 IV is given as an injection by a healthcare professional. Take Hemorise 500 IV 500 mg/10 ml injection by mouth as directed by your doctor. If you miss a dose, ask your doctor or pharmacist what to do. Follow the doctor's instructions about follow-up and any tests.
Hemorise 500 IV-এর পার্শ্বপ্রতিক্রিয়া
Serious allergic-type reactions, including anaphylactic-type reactions, have been reported and can be life-threatening. Some people may have nausea, vomiting, headache, dizziness, flushing, itching, rash, hives, wheezing, constipation, low blood pressure, a bitter taste, injection site discolouration, or changes in blood phosphorus and liver enzyme tests. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
সতর্কতা ও নিরাপত্তা
Breastfeeding mothers, people with other medical conditions, and those taking other medicines should ask the doctor first. It is pregnancy category C, so ask your doctor whether it is suitable if you are pregnant, planning pregnancy, or breastfeeding. Tell the doctor about allergies, pregnancy, breastfeeding and other medicines before treatment. Tell your doctor before treatment if you have had an allergic reaction to iron products or to any ingredient in this injection.
সাধারণ প্রশ্ন
What does Hemorise 500 IV treat?
It is intended for people who do not tolerate iron taken by mouth or who have not had a satisfactory response to oral iron. Hemorise 500 IV is used to treat iron deficiency anemia in adults who have intolerance to oral iron or an unsatisfactory response to oral iron, and in adults with non-dialysis dependent chronic kidney disease.
How is Hemorise 500 IV used?
You should not self-administer it. Do not inject it yourself unless a doctor has shown you how.
What should I watch for while using Hemorise 500 IV?
Serious allergic-type reactions, including anaphylactic-type reactions, have been reported and can be life-threatening. Some people may have nausea, vomiting, headache, dizziness, flushing, itching, rash, hives, wheezing, constipation, low blood pressure, a bitter taste, injection site discolouration, or changes in blood phosphorus and liver enzyme tests.
Who should be careful with Hemorise 500 IV?
Breastfeeding mothers, people with other medical conditions, and those taking other medicines should ask the doctor first. It is pregnancy category C, so ask your doctor whether it is suitable if you are pregnant, planning pregnancy, or breastfeeding.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-- Who have intolerance to oral iron or have had unsatisfactory response to oral iron
- Who have non-dialysis dependent chronic kidney disease.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.
The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.
Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.
When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.
Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.
Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There are no known drug interactions and none well documented.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity to any of its components.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactionsগর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risksসতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.Hypertension: Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Do not store above 30°C. Do not freeze.বিকল্প ব্র্যান্ড: Ferric Carboxymaltose
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
Jectofer Injection Injection
500 mg/10 ml
Globe Pharmaceuticals Ltd.
৳ ৬৮৬ ৳ ৭০০ ২% ছাড় প্রতি ইউনিট
Ferox 15 ml IV Injection/Infus Injection
750 mg/15 ml
Advanced Chemical Industries PLC
দাম দেওয়া নেই
Ferox 20 ml IV Injection/Infus Injection
1000 mg/20 ml
Advanced Chemical Industries PLC
দাম দেওয়া নেই
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।